
Dr. Reddy's Laboratories Ltd: shareholders and insiders
Price
$14.89
November 20, 2026Market cap $12.4B
What Ploutos Investor adds for Dr. Reddy's Laboratories
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from FY2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Sorry, we do not have enough data
for purchases and sales by Dr. Reddy's Laboratories's insiders
Why?
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- G.V. Prasadwith 5 more personsAmerican depositary shares, each representing one equity shareShare of class13.6%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| G.V. Prasadwith 5 more personsAmerican depositary shares, each representing one equity share | 13.6% | 113M | Sep 18, 2025 | 13D/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
G.V. Prasad13.6%From the filing of Sep 18, 2025
Item 4 of the Amended Schedule 13D is hereby amended and supplemented as follows: On September 17, 2025, Mr. G.V. Prasad transferred 96,095,920 Post-Split Shares to GVP Family Trust and Mr. K. Satish Reddy transferred 75,630,620 Post-Split Shares to VSD Family Trust. These transfers of shares were done for estate planning purposes, and to implement family succession arrangements and planning for a smooth and streamlined transfer of family assets and businesses.
From the filing of Sep 18, 2025
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- BlackRock, Inc.4.10%Apr 28, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter-5.0%
- Millennium Mgmt (Englander)In the quarter+495%
- Citadel Advisors (Griffin)In the quarter×14.2
- Point72 (Cohen)In the quarter
- D.E. ShawIn the quarter+158%
- AQR CapitalIn the quarter+5.2%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 6.98M | -5.0% | $88M | 0.12% |
| Millennium Mgmt (Englander) | 2.79M | +495% | $35M | 0.03% |
| Citadel Advisors (Griffin) | 1.12M | ×14.2 | $14M | 0.01% |
| Point72 (Cohen) | 49.2K | $600.0K | 0.00% | |
| D.E. Shaw | 325.9K | +158% | $4.1M | 0.00% |
| AQR Capital | 581.4K | +5.2% | $7.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 3.13% of its shares outstanding were held short, -7.9% since the report before.
- Shares held short
- 26.14M
- 3.13%
- Since the report before28.39M on Sep 30, 2026
- -7.9%
- 8.5
- 3.09M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 85%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.27M
- Nov 15, 2023: Shares held short 1.06M
- Nov 30, 2023: Shares held short 1.16M
- Dec 15, 2023: Shares held short 1.10M
- Dec 29, 2023: Shares held short 849.5K
- Jan 12, 2024: Shares held short 736.1K
- Jan 31, 2024: Shares held short 768.0K
- Feb 15, 2024: Shares held short 693.5K
- Feb 29, 2024: Shares held short 648.1K
- Mar 15, 2024: Shares held short 709.3K
- Mar 28, 2024: Shares held short 625.8K
- Apr 15, 2024: Shares held short 751.0K
- Apr 30, 2024: Shares held short 867.9K
- May 15, 2024: Shares held short 974.4K
- May 31, 2024: Shares held short 1.17M
- Jun 14, 2024: Shares held short 1.89M
- Jun 28, 2024: Shares held short 1.99M
- Jul 15, 2024: Shares held short 1.94M
- Jul 31, 2024: Shares held short 1.89M
- Aug 15, 2024: Shares held short 2.27M
- Aug 30, 2024: Shares held short 2.06M
- Sep 13, 2024: Shares held short 2.30M
- Sep 30, 2024: Shares held short 2.15M
- Oct 15, 2024: Shares held short 2.20M
- Oct 31, 2024: Shares held short 2.14M
- Nov 15, 2024: Shares held short 11.64M
- Nov 29, 2024: Shares held short 11.04M
- Dec 13, 2024: Shares held short 10.83M
- Dec 31, 2024: Shares held short 13.11M
- Jan 15, 2025: Shares held short 12.11M
- Jan 31, 2025: Shares held short 15.90M
- Feb 14, 2025: Shares held short 18.46M
- Feb 28, 2025: Shares held short 18.26M
- Mar 14, 2025: Shares held short 16.10M
- Mar 31, 2025: Shares held short 14.90M
- Apr 15, 2025: Shares held short 15.65M
- Apr 30, 2025: Shares held short 14.93M
- May 15, 2025: Shares held short 14.93M
- May 30, 2025: Shares held short 14.23M
- Jun 13, 2025: Shares held short 12.47M
- Jun 30, 2025: Shares held short 10.94M
- Jul 15, 2025: Shares held short 12.19M
- Jul 31, 2025: Shares held short 9.89M
- Aug 15, 2025: Shares held short 9.43M
- Aug 29, 2025: Shares held short 9.46M
- Sep 15, 2025: Shares held short 9.97M
- Sep 30, 2025: Shares held short 9.65M
- Oct 15, 2025: Shares held short 8.55M
- Oct 31, 2025: Shares held short 8.54M
- Nov 14, 2025: Shares held short 8.05M
- Nov 28, 2025: Shares held short 9.21M
- Dec 15, 2025: Shares held short 10.11M
- Dec 31, 2025: Shares held short 12.30M
- Jan 15, 2026: Shares held short 12.59M
- Jan 30, 2026: Shares held short 12.53M
- Feb 13, 2026: Shares held short 12.80M
- Feb 27, 2026: Shares held short 13.48M
- Mar 13, 2026: Shares held short 13.73M
- Mar 31, 2026: Shares held short 14.65M
- Apr 15, 2026: Shares held short 13.24M
- Apr 30, 2026: Shares held short 15.72M
- May 15, 2026: Shares held short 20.18M
- May 29, 2026: Shares held short 22.39M
- Jun 15, 2026: Shares held short 22.85M
- Jun 30, 2026: Shares held short 23.19M
- Jul 15, 2026: Shares held short 20.98M
- Jul 31, 2026: Shares held short 20.89M
- Aug 14, 2026: Shares held short 22.51M
- Aug 31, 2026: Shares held short 23.90M
- Sep 15, 2026: Shares held short 28.96M
- Sep 30, 2026: Shares held short 28.39M
- Oct 15, 2026: Shares held short 26.14M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading52.6% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 52.6% of the shares in the reported trades were short sales, against 45.6% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 52.6%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 45.6%
- Change
- +7.0 pts
- Short sales a dayon average, of 679.2K shares
- 357.0K
- More than atof 3,666 US-listed companies, same days
- 58%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 48.6%
- Oct 15, 2026: Short sales 59.5%
- Oct 16, 2026: Short sales 51.2%
- Oct 19, 2026: Short sales 58%
- Oct 20, 2026: Short sales 34.4%
- Oct 21, 2026: Short sales 59.8%
- Oct 22, 2026: Short sales 46.2%
- Oct 23, 2026: Short sales 45.8%
- Oct 26, 2026: Short sales 40.9%
- Oct 27, 2026: Short sales 32.4%
- Oct 28, 2026: Short sales 55.3%
- Oct 29, 2026: Short sales 30.5%
- Oct 30, 2026: Short sales 63.5%
- Nov 2, 2026: Short sales 43.3%
- Nov 3, 2026: Short sales 43.5%
- Nov 4, 2026: Short sales 41%
- Nov 5, 2026: Short sales 59.5%
- Nov 6, 2026: Short sales 61%
- Nov 9, 2026: Short sales 56.3%
- Nov 10, 2026: Short sales 36.2%
- Nov 11, 2026: Short sales 44%
- Nov 12, 2026: Short sales 65.7%
- Nov 13, 2026: Short sales 64.5%
- Nov 16, 2026: Short sales 38.5%
- Nov 17, 2026: Short sales 54.8%
- Nov 18, 2026: Short sales 57.6%
- Nov 19, 2026: Short sales 56.8%
- Nov 20, 2026: Short sales 58.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- FLINFranklin FTSE India ETFWeight in the fund0.52%
- INDAiShares MSCI India ETFWeight in the fund0.44%
- EEMViShares MSCI Emerging Markets Min Vol Factor ETFWeight in the fund0.34%
- SPEMState Street(R) SPDR(R) Portfolio Emerging Markets ETFWeight in the fund0.12%
- AVEMAvantis Emerging Markets Equity ETFWeight in the fund0.08%
- SCHESchwab Emerging Markets Equity ETFWeight in the fund0.07%
- EMXCiShares MSCI Emerging Markets ex China ETFWeight in the fund0.06%
- VWOVanguard Emerging Markets Stock Index FundWeight in the fund0.06%
- AAXJiShares MSCI All Country Asia ex Japan ETFWeight in the fund0.06%
- EEMiShares MSCI Emerging Markets ETFWeight in the fund0.05%
20 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 228
- Q4 2025: Managers 237
- Q1 2026: Managers 250
- Q2 2026: Managers 238
Institutional investors by quarter
The fund managers holding RDY, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 238 managers held 126M shares, worth $1.8B. During the quarter 30 opened a position, 42 closed one, 75 added and 96 trimmed.
The largest holders, Q2 2026
- Robeco Institutional Asset Management B.V.In the quarter+4.9%
- Morgan StanleyIn the quarter+17%
- BlackRockIn the quarter-8.6%
- Royal Bank of CanadaIn the quarter-7.7%
- Aikya Investment ManagementIn the quarter+6.2%
- Renaissance TechnologiesIn the quarter-6.5%
- Dimensional Fund AdvisorsIn the quarter-0.2%
- State StreetIn the quarter+2.4%
- JPMorgan ChaseIn the quarter-6.9%
- AlliancebernsteinIn the quarter+47%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Robeco Institutional Asset Management B.V. | 18.02M | +4.9% | $261M |
| Morgan Stanley | 10.94M | +17% | $158M |
| BlackRock | 10.59M | -8.6% | $153M |
| Royal Bank of Canada | 9.21M | -7.7% | $134M |
| Aikya Investment Management | 8.49M | +6.2% | $123M |
| Renaissance Technologies | 7.35M | -6.5% | $106M |
| Dimensional Fund Advisors | 5.31M | -0.2% | $77M |
| State Street | 4.12M | +2.4% | $60M |
| JPMorgan Chase | 4.07M | -6.9% | $60M |
| Alliancebernstein | 3.73M | +47% | $52M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Dr. Reddy's Laboratories's filings show?
Who buys and sells is one part of Dr. Reddy's Laboratories's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have RDY's insiders bought or sold?
From – to – Dr. Reddy's Laboratories's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold RDY?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $88M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.